SPRB (Spruce Biosciences, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
Spruce Biosciences, Inc. Common Stock (SPRB) is a publicly traded the market company. As of May 21, 2026, SPRB trades at $52.56 with a market cap of $138.92M and a P/E ratio of -1.02. SPRB moved +7.09% today. Year to date, SPRB is -37.27%; over the trailing twelve months it is +429.99%. Its 52-week range spans $4.28 to $240.00. Analyst consensus is strong buy with an average price target of $178.60. Rallies surfaces SPRB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns SPRB stock?
Hedge funds tracked by Rallies that own SPRB include Panagora Asset. The latest tracked quarter is Mar 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Spruce Biosciences, Inc. Common Stock.
SPRB Key Metrics
Key financial metrics for SPRB
Metric
Value
Price
$52.56
Market Cap
$138.92M
P/E Ratio
-1.02
EPS
$-50.83
Dividend Yield
0.00%
52-Week High
$240.00
52-Week Low
$4.28
Volume
34
Avg Volume
0
Revenue (TTM)
$0
Net Income
$-38.97M
Gross Margin
0.00%
Top Hedge Funds Holding SPRB
Panagora Asset holds 253.68K shares of SPRB, changed +0.00% as of Mar 31, 2024.
Hedge funds tracked by Rallies that own SPRB include Panagora Asset. The latest tracked quarter is Mar 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Spruce Biosciences, Inc. Common Stock.
Does Rallies show 13F holders for SPRB?
Yes. Rallies tracks hedge fund and 13F ownership data for SPRB, including fund names, share counts, latest tracked quarter, and position changes when available.
Is SPRB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SPRB. It does not provide personalized investment advice.